Analyst Downgrades – Anthera Pharmaceuticals (NASDAQ:ANTH) Stock Gets Downgraded By Piper Jaffray Companies from Overweight to Underweight

Analyst Ratings For Anthera Pharmaceuticals (NASDAQ:ANTH)

Today, Anthera Pharmaceuticals (NASDAQ:ANTH) stock was downgraded by Piper Jaffray Companies from Overweight to Underweight.

Some recent analyst ratings include

  • 3/12/2018-Piper Jaffray Companies was Downgraded by analysts at Piper Jaffray Companies from a “Overweight ” rating to a ” Underweight” rating.
  • 3/6/2018-HC Wainwright Reiterated Rating of Buy.
  • 2/21/2018-Roth Capital initiated coverage with a Buy rating.
  • 8/11/2017-Jefferies Group Reiterated Rating of Hold.
  • 12/29/2016-Citigroup was Downgraded by analysts at Citigroup from a “Buy ” rating to a ” Neutral” rating.
  • 12/28/2016-SunTrust Banks was Downgraded by analysts at SunTrust Banks from a “Buy ” rating to a ” Hold” rating. They now have a $8.00 price target on the stock, up previously from $48.00 .
  • 6/20/2016-FBR & Co Reiterated Rating of Hold.

Recent Insider Trading Activity For Anthera Pharmaceuticals (NASDAQ:ANTH)
Anthera Pharmaceuticals (NASDAQ:ANTH) has insider ownership of 2.08% and institutional ownership of 28.12%.

  • On 9/20/2017 John Craig Thompson, CEO, bought 8,550 with an average share price of $1.32 per share and the total transaction amounting to $11,286.00.
  • On 9/7/2017 John Craig Thompson, CEO, bought 10,400 with an average share price of $1.43 per share and the total transaction amounting to $14,872.00.
  • On 9/7/2017 Paul F Truex, Director, bought 5,000 with an average share price of $1.34 per share and the total transaction amounting to $6,700.00.
  • On 11/13/2015 Colin Hislop, insider, sold 12,500 with an average share price of $5.31 per share and the total transaction amounting to $66,375.00.
  • On 11/11/2015 Colin Hislop, Insider, sold 5,000 with an average share price of $5.38 per share and the total transaction amounting to $26,900.00.
  • On 10/12/2015 Debra Odink, CTO, sold 1,205 with an average share price of $6.15 per share and the total transaction amounting to $7,410.75.
  • On 6/24/2013 David E Thompson, Director, bought 12,500 with an average share price of $0.53 per share and the total transaction amounting to $6,625.00.

Recent Trading Activity for Anthera Pharmaceuticals (NASDAQ:ANTH)
Shares of Anthera Pharmaceuticals closed the previous trading session at 0.50 down -2.14 81.11% with 33135914 shares trading hands.

An ad to help with our costs